LOGIN  |  REGISTER
C4 Therapeutics
Amneal Pharmaceuticals

Waters Appoints Heather Knight to Board of Directors

August 14, 2024 | Last Trade: US$377.10 5.34 1.44

MILFORD, Mass., Aug. 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the appointment of Heather Knight to its Board of Directors effective August 14, 2024. Ms. Knight currently serves as Executive Vice President and Group President, Medical Products and Therapies at Baxter International.

Waters Corporation appointed Heather Knight to its Board of Directors. She currently serves as Executive Vice President and Group President, Medical Products & Therapies at Baxter International.

"Heather is an accomplished leader who brings decades of experience across the pharmaceutical and medical device industries, with a proven track record for driving growth and innovation," said Dr. Flemming Ornskov, Chair of the Board. "Her experience enriches the diverse skills and backgrounds of our Board members, which is instrumental in our oversight of the strategy and in enhancing shareholder value."

"We are thrilled to welcome Heather to our Board of Directors," said Dr. Udit Batra, President and CEO, Waters Corporation. "Her commitment to operational excellence coupled with her global experience driving commercial execution and portfolio innovation across the MedTech industry will be complementary to our Board. I look forward to collaborating with her as we advance our growth strategy."

"It's an honor to join the Waters Board of Directors at such an exciting time," commented Heather Knight, Executive Vice President and Group President of Medical Products and Therapies at Baxter International. "I've long admired the company and look forward to contributing to its success."

Ms. Knight currently serves as the Executive Vice President and Group President of Medical Products and Therapies at Baxter International. She brings nearly three decades of global business and commercial leadership experience in the pharmaceutical and medical device industries, and a proven track record of driving strong execution, business transformation, and portfolio innovation. She holds a B.S. in Biology from the University of Buffalo.

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,500 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

Contact:
Kevin Kempskie
Senior Director Public Relations
Waters Corporation
This email address is being protected from spambots. You need JavaScript enabled to view it.
+1.508.478.2000

 
C4 Therapeutics

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page